OHSU Knight Cancer Institute Research Groups:

Program 3 Members

 * Molly Kulesz-Martin
 * Epithelial Cell Homeostasis and Carcinogenesis and Novel Targets for Molecular Therapy


 * Alan Sandler
 * Lung & Thoracic Cancer


 * Mike Heinrich & Chris Corless
 * Development of novel tyrosine kinase inhibitors for treatment of human cancers (Heinrich) & immunohistochemical and molecular testing to evaluate novel therapeutic targets (Corless)